Understanding the Distinction: Is Rituximab a Biohazard?
•
4 min read
According to the National Institute for Occupational Safety and Health (NIOSH), the monoclonal antibody rituximab does not meet the criteria for a hazardous drug, and it is explicitly not a biohazard because it contains no microorganisms. This distinction is crucial for understanding the appropriate handling and safety protocols for this potent medication.
